Intention-to-treat analysis: Who is in? Who is out? - Brief Report

Journal of Family Practice, Nov, 2002 by Robin L. Kruse, Brian S. Alper, Carin Reust, James J. Stevermer, Scott Shannon, Randy H. Williams

(4.) Montori VM, Guyatt GH. Intention-to-treat principle CMAJ 2001: 165:1339-41.

(5.) Hennekens CH, Buring JE, Mayrent SL. Epidemiology in Medicine. 1st ed. Boston: Little, Brown: 1987:207.

(6.) Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134:663-94.

(7.) Lewis JA, Machin D. Intention to treat--who should use ITT? Br J Cancer 1993; 68:647-50.

(8.) Hollis S, Campbell F. What is meant by retention to treat analysis? Survey of published randomised controlled trials. BMJ 1999; 319:670-4.

(9.) Schulz KF, Grimes DA, Altman DG, Hayes RJ. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology. BMJ 1996; 312:742-4.

(10.) Ruiz-Canela M, Martinez-Gonzalez MA, de Irala-Estevez J. Intention to treat analysis is related to methodological quality. BMJ 2000; 320:1007-8.

(11.) Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators. Lancet 1999; 353:14-7.

(12.) Winnock M, Rancinan C, De Ledinghen V, Couzigou P, Chene G. What hides behind an intention-to-treat analysis? Hepatology 2001: 33:1014-5.

ROBIN L. KRUSE, PHD; BRIAN S. ALPER, MD, MSPH; CARIN REUST, MD, MSPH; JAMES J. STEVERMER, MD, MSPH; SCOTT SHANNON, MD; AND RANDY H. WILLIAMS, PHD

Columbia, Hallsville, and Jefferson City, Missouri

From the Department of Family and Community Medicine, University of Missouri-Columbia School of Medicine, Columbia, MO (R.L.K., B.S.A., J.J.S., S.S.); University Physicians-Hallsville, Hallsville, MO (C.R.); and the Missouri Department of Health and Senior Services, Division of Chronic Disease Prevention and Health Promotion, Office of Surveillance, Research and Evaluation, Jefferson City, MO (R.H.W). The authors report no competing interests. Address reprint requests to Robin L. Kruse, PhD, Department of Family and Community Medicine, University of Missouri-Columbia School of Medicine, M228 Medical Sciences Building, Columbia, MO 65212. E-mail: KruseR@health.missouri.edu.